figaro-dkd trial results
Published 3 years ago • 1.8K plays • Length 4:44Download video MP4
Download video MP3
Similar videos
-
3:21
fidelio dkd results
-
3:59
esc tv at #esccongress 2021 - figaro-dkd
-
6:27
fidelio-dkd and figaro-dkd trial summary - finrenone
-
7:22
figaro: where will finerenone fit into diabetic kidney disease treatment | david wheeler
-
4:00
dr rajiv agarwal discusses finerenone, results of fidelio-dkd
-
14:25
insights from the figaro-dkd and fidelio-dkd trials - english language - dr. gawad
-
54:16
effects of canagliflozin versus finerenone on cardiorenal outcomes
-
26:55
dr. rajeev agrawal - insights from the fidelio-dkd and figaro-dkd trial
-
23:52
all about oil-the right quality and quantity | dr. shashank joshi | the interview
-
39:55
the current concepts of use of acei / arb, sglt2 inhibitors & finerenone in ckd |dr. ashok kirpalani
-
1:00:28
#454 kidney boy on managing diabetes and hypertension in ckd
-
56:20
finerenone investor-webinar
-
3:07
dr george bakris compares fidelio-dkd renal outcomes with those of sglt-2 inhibitor trials
-
34:04
george bakris, md | use of finerenone in patients with diabetes who have kidney disease
-
5:45
esc 2022: fidelity: finerenone in pts with chronic kidney disease | prof gerasimos filippatos
-
43:31
fidelio block-ckd dr. bakris (chicago)
-
1:06:19
discovery of finerenone | dr lars bärfacker (bayer) | society of chemical industry ycp/fcg webinar
-
10:10
empa-kidney results
-
18:00
dkd treatment update: sglt2 inhibitors and finerenone | ian de boer & amrit lamba
-
39:56
the role of novel nonsteroidal mineralocorticoid receptor antagonists in chronic kidney disease
-
48:12
mineralocorticoid axis in health and disease- history, evolution and clinical implications
-
3:41
jennifer green, easd 2022: finerenone & empagliflozin in patients with ckd and t2d: confidence study